Skip to main content
Lunit Inc. logo

Lunit Inc. — Investor Relations & Filings

Ticker · 328130 ISIN · KR7328130000 KO Telecommunications, computer programming, consultancy, computing infrastructure, and other information service activities
Open in API
Filings indexed 317 across all filing types
Latest filing 2023-01-18 Regulatory Filings
Country KR South Korea
Listing KO 328130

About Lunit Inc.

https://www.lunit.io/

Lunit Inc. develops and provides advanced medical artificial intelligence (AI) software focused on cancer diagnostics and therapeutics. The company's core offering is a platform-based AI ecosystem designed to analyze and interpret medical data, including radiological images and pathology slides. Its solutions, such as the Lunit INSIGHT suite for mammography and chest X-ray analysis, assist healthcare professionals in the early detection of cancer, enhancing diagnostic accuracy and workflow efficiency. In precision oncology, Lunit's AI technology supports biomarker discovery and treatment response prediction by analyzing tissue pathology. The company also collaborates with biopharmaceutical partners to accelerate oncology drug development and create AI-powered companion diagnostics. Lunit's platform integrates multimodal data to provide actionable insights across the cancer care continuum, from screening to treatment.

Recent filings

Filing Released Lang Actions
기타경영사항(자율공시)(식약처, 인공지능 기반 디지털 유방 단층촬영술 영상 진단 보조 소프트웨어(Lunit INSIGHT DBT) 수출용 허가)
Regulatory Filings Classification · 1% confidence The document is a voluntary disclosure (자율공시) regarding a regulatory approval (export license) for a medical software product (Lunit INSIGHT DBT) from the Ministry of Food and Drug Safety. It does not fit into specific financial reporting categories like 10-K, IR, or ER, nor is it a report publication announcement. As it is a general regulatory announcement regarding company operations, it falls under the RNS (Regulatory Filings) category.
2023-01-18 Korean
기업설명회(IR)개최
Report Publication Announcement Classification · 1% confidence The document is a formal announcement regarding an upcoming Investor Relations (IR) event (기업설명회). It provides details such as the date, location (San Francisco), purpose (company introduction and business status), and contact information. Since it is an announcement of an event rather than the presentation materials themselves, and it is a regulatory disclosure filed with the Korea Exchange, it fits the definition of a general regulatory filing or announcement regarding corporate activities.
2023-01-06 Korean
기타경영사항(자율공시)(특허권 취득(정상 의료 영상을 필터링하는 방법, 이를 이용한 의료 영상 판독 방법 및 컴퓨팅 장치))
Regulatory Filings Classification · 1% confidence The document is a voluntary disclosure ('자율공시') by Lunit regarding the acquisition of a patent ('특허권 취득'). It details the patent name, technical content, and its application in medical imaging AI. Since this is a regulatory announcement of a specific corporate event (patent acquisition) that does not fit into financial reporting, governance, or shareholder meeting categories, it falls under the general regulatory filing category.
2022-12-26 Korean
기타경영사항(자율공시)(특허권 취득(기흉 검출 방법 및 시스템))
Regulatory Filings Classification · 1% confidence The document is a voluntary disclosure ('자율공시') regarding the acquisition of a patent ('특허권 취득') by the company Lunit. It details the patent name, technical content, and its strategic application for the company's AI medical business. Since this is a specific corporate announcement regarding business operations that does not fit into financial reporting, dividend, or governance categories, it falls under the general regulatory filing category.
2022-12-26 Korean
기타경영사항(자율공시)(특허권 취득(기계학습을 이용한 의료 영상 판독의 품질 관리 방법 및 장치))
Regulatory Filings Classification · 1% confidence The document is a voluntary disclosure ('자율공시') regarding the acquisition of a patent ('특허권 취득') by Lunit. It details the patent name, the technology involved, and its strategic application. Since this is a regulatory announcement of a specific corporate event (patent acquisition) that does not fit into financial reporting, governance, or shareholder meeting categories, it falls under the general regulatory filing category.
2022-12-19 Korean
주주명부폐쇄기간또는기준일설정
Regulatory Filings Classification · 1% confidence The document is a short regulatory announcement regarding the setting of a record date for the purpose of holding an Annual General Meeting (AGM). It does not contain the full meeting materials or proxy statements, but rather serves as a formal notice of the record date for shareholder rights. Given its nature as a regulatory notification regarding meeting preparation, it fits best under the RNS (Regulatory Filings) category as it is a standard corporate disclosure.
2022-12-14 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.